XML 78 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment and Geographic Area Information (Tables)
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Summarized Financial Information by Reportable Segments
Year Ended December 31,
202120202019
(In thousands)
Net sales:
Lithium$1,363,284 $1,144,778 $1,358,170 
Bromine1,128,343 964,962 1,004,216 
Catalysts761,235 797,914 1,061,817 
All Other75,095 221,255 165,224 
Total net sales$3,327,957 $3,128,909 $3,589,427 
Adjusted EBITDA:
Lithium$479,538 $393,093 $524,934 
Bromine360,682 323,605 328,457 
Catalysts106,941 130,134 270,624 
All Other29,858 84,821 49,628 
Corporate(106,045)(112,915)(136,862)
Total adjusted EBITDA$870,974 $818,738 $1,036,781 
See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands):
LithiumBromineCatalystsReportable Segments TotalAll OtherCorporateConsolidated Total
2021
Net income (loss) attributable to Albemarle Corporation$192,244 $309,501 $55,353 $557,098 $27,988 $(461,414)$123,672 
Depreciation and amortization138,772 51,181 51,588 241,541 1,870 10,589 254,000 
Restructuring and other(a)
— — — — — 3,027 3,027 
Gain on sale of business/interest in properties, net(b)
132,400 — — 132,400 — (428,371)(295,971)
Acquisition and integration related costs(c)
— — — — — 12,670 12,670 
Interest and financing expenses(d)
— — — — — 61,476 61,476 
Income tax expense— — — — — 29,446 29,446 
Non-operating pension and OPEB items— — — — — (78,814)(78,814)
Legacy Rockwood legal matter(d)
— — — — — 657,412 657,412 
Albemarle Foundation contribution(e)
— — — — — 20,000 20,000 
Indemnification adjustments(f)
— — — — — 39,381 39,381 
Other(g)
16,122 — — 16,122 — 28,553 44,675 
Adjusted EBITDA$479,538 $360,682 $106,941 $947,161 $29,858 $(106,045)$870,974 
2020
Net income (loss) attributable to Albemarle Corporation$277,711 $274,495 $80,149 $632,355 $76,323 $(332,914)$375,764 
Depreciation and amortization112,854 50,310 49,985 213,149 8,498 10,337 231,984 
Restructuring and other(a)
— — — — — 19,597 19,597 
Acquisition and integration related costs(c)
— — — — — 17,263 17,263 
Interest and financing expenses— — — — — 73,116 73,116 
Income tax expense— — — — — 54,425 54,425 
Non-operating pension and OPEB items— — — — — 40,668 40,668 
Other(h)
2,528 (1,200)— 1,328 — 4,593 5,921 
Adjusted EBITDA$393,093 $323,605 $130,134 $846,832 $84,821 $(112,915)$818,738 
2019
Net income (loss) attributable to Albemarle Corporation$341,767 $279,945 $219,686 $841,398 $41,188 $(349,358)$533,228 
Depreciation and amortization99,424 47,611 50,144 197,179 8,440 7,865 213,484 
Restructuring and other(a)
— — — — — 5,877 5,877 
Gain on sale of property(i)
— — — — — (14,411)(14,411)
Acquisition and integration related costs(c)
— — — — — 20,684 20,684 
Interest and financing expenses(j)
— — — — — 57,695 57,695 
Income tax expense— — — — — 88,161 88,161 
Non-operating pension and OPEB items— — — — — 26,970 26,970 
Stamp duty(c)
64,766 — — 64,766 — — 64,766 
Windfield tax settlement(k)
17,292 — — 17,292 — — 17,292 
Other(l)
1,685 901 794 3,380 — 19,655 23,035 
Adjusted EBITDA$524,934 $328,457 $270,624 $1,124,015 $49,628 $(136,862)$1,036,781 
(a)In 2021, we recorded facility closure related to offices in Germany, and severance expenses in Germany and Belgium, in SG&A. During the year ended December 31, 2020, we recorded severance expenses as part of business reorganization plans, impacting each of our businesses and Corporate, primarily in the U.S., Belgium, Germany and with our Jordanian joint venture partner. We recorded expenses of $0.7 million in Cost of goods sold, $19.2 million in SG&A and a $0.3 million gain in Net income attributable to noncontrolling interests for the portion of severance expense allocated to our Jordanian joint venture partner. In addition, we recorded severance payments as part of a business reorganization plans in Selling, general and administrative expenses for the year ended December 31,
2019. The balance of unpaid restructuring costs and severance is recorded in Accrued expenses and is expected to primarily be paid through 2022.
(b)Includes a $428.4 million gain related to the FCS divestiture recorded during the year ended December 31, 2021. See Note 3, “Divestitures,” for additional information on this gain. In addition, includes a $132.4 million expense related to anticipated cost overruns for MRL’s 40% interest in lithium hydroxide conversion assets being built in Kemerton. See Note 2, “Acquisitions,” for additional information.
(c)See Note 2, “Acquisitions,” for additional information.
(d)Loss recorded in Other expenses, net for the year ended December 31, 2021 related to the settlement of an arbitration ruling for a legacy Rockwood legal matter. See Note 17, “Commitments and Contingencies,” for further details.
(e)Included in SG&A is a charitable contribution, using a portion of the proceeds received from the FCS divestiture, to the Albemarle Foundation, a non-profit organization that sponsors grants, health and social projects, educational initiatives, disaster relief, matching gift programs, scholarships and other charitable initiatives in locations where our employees live and the Company operates. This contribution is in addition to the normal annual contribution made to the Albemarle Foundation by the Company, and is significant in size and nature in that it is intended to provide more long-term benefits in these communities.
(f)Included in Other expenses, net to revise an indemnification estimate for an ongoing tax-related matter of a previously disposed business in Germany. A corresponding discrete tax benefit of $27.9 million was recorded in Income tax expense during the same period, netting to an expected cash obligation of approximately $11.5 million.
(g)Included amounts for the year ended December 31, 2021 recorded in:
•Cost of goods sold - $10.5 million of expense related to a legal matter as part of a prior acquisition in our Lithium business.
•SG&A - $11.5 million of legal fees related to a legacy Rockwood legal matter noted above, $9.8 million of expenses primarily related to non-routine labor and compensation related costs that are outside normal compensation arrangements, a $4.0 million loss resulting from the sale of property, plant and equipment and $3.8 million of charges for environmental reserves at a sites not part of our operations.
•Other expenses, net - $4.8 million of net expenses primarily related to asset retirement obligation charges to update of an estimate at a site formerly owned by Albemarle.
(h)Included amounts for the year ended December 31, 2020 recorded in:
•Cost of goods sold - $1.3 million of expense related to a legal matter as part of a prior acquisition in our Lithium business.
•SG&A - $3.1 million of shortfall contributions for our multiemployer plan financial improvement plan and $3.8 million of a net expense primarily relating to the increase of environmental reserves at non-operating businesses we have previously divested.
•Other expenses, net - $7.2 million gain related to the sale of our ownership percentage in the SOCC joint venture, $3.6 million of a net gain primarily relating to the sale of intangible assets in our Bromine business and property in Germany not used as part of our operations and a $2.5 million net gain resulting from the settlement of legal matters related to a business sold or a site in the process of being sold, partially offset by $9.6 million of losses resulting from the adjustment of indemnifications related to previously disposed businesses and $1.2 million of expenses related to other costs outside of our regular operations.
(i)Gain of $3.3 million recorded in Selling, general and administrative expenses related to the release of liabilities as part of the sale of a property and $11.1 million gain recorded in Other expenses, net related to the sale of land in Pasadena, Texas not used as part of our operations.
(j)Included in Interest and financing expenses is a loss on early extinguishment of debt of $4.8 million. See Note 14, “Long-Term Debt,” for additional information.
(k)Represents our 49% share of a tax settlement between our Windfield joint venture and an Australian taxing authority, recorded in Equity in net income of unconsolidated investments (net of tax). This is offset in Income tax expense by a discrete tax benefit related to seeking treaty relief from the competent authority to prevent double taxation.
(l)Included amounts for the year ended December 31, 2019 recorded in:
•Cost of goods sold - $0.7 million related to non-routine labor and compensation related costs in Chile that are outside normal compensation arrangements.
•Selling, general and administrative expenses - $1.8 million of shortfall contributions for our multiemployer plan financial improvement plan, $0.9 million of a write-off of uncollectible accounts receivable from a terminated distributor in the Bromine segment, $1.0 million related to the settlement of terminated agreements, primarily in the Catalysts segment, and $0.8 million related to the settlement of an ongoing audit in the Lithium segment.
•Other expenses, net - $3.1 million of unrecoverable vendor costs outside the operations of the business related to the construction of the future Kemerton production facility, $9.8 million of a net loss primarily resulting from the adjustment of indemnifications and other liabilities related to previously disposed businesses or purchase accounting, $3.6 million of asset retirement obligation charges related to the update of an estimate at a site formerly owned by Albemarle, and $1.2 million of non-operating pension costs from our 50% interest in JBC.
December 31,
202120202019
(In thousands)
Identifiable assets:
Lithium(a)
$7,676,259 $7,134,229 $6,570,791 
Bromine939,808 867,648 799,456 
Catalysts1,149,592 1,066,089 1,163,590 
All Other— 136,659 146,211 
Corporate1,208,459 1,246,321 1,180,815 
Total identifiable assets$10,974,118 $10,450,946 $9,860,863 
(a)Increase in Lithium identifiable assets each year primarily due to capital expenditures for growth and capacity increases.
Year Ended December 31,
202120202019
(In thousands)
Depreciation and amortization:
Lithium$138,772 $112,854 $99,424 
Bromine51,181 50,310 47,611 
Catalysts51,588 49,985 50,144 
All Other1,870 8,498 8,440 
Corporate10,589 10,337 7,865 
Total depreciation and amortization$254,000 $231,984 $213,484 
Capital expenditures:
Lithium$813,128 $720,563 $665,585 
Bromine70,711 57,486 82,208 
Catalysts49,312 44,448 57,939 
All Other2,339 6,792 7,309 
Corporate18,177 21,188 38,755 
Total capital expenditures$953,667 $850,477 $851,796 
Net Sales by Geographic Area
Year Ended December 31,
202120202019
(In thousands)
Net Sales(a):
United States$730,738 $743,834 $858,084 
Foreign(b)
2,597,219 2,385,075 2,731,343 
Total$3,327,957 $3,128,909 $3,589,427 
(a)Net sales are attributed to countries based upon shipments to final destination.
(b)In 2021, net sales to China, Japan and Korea represented 18%, 14% and 11%, respectively, of total net sales. In 2020, net sales to Korea, China and Japan represented 14%, 14%, and 13%, respectively, of total net sales. In 2019, net sales to Korea, China and Japan represented 17%, 13%, and 12%, respectively, of total net sales.
Long-Lived Assets by Geographic Area
As of December 31,
202120202019
(In thousands)
Long-Lived Assets(a):
United States$1,040,252 $1,007,793 $1,003,496 
Australia2,736,590 2,362,377 1,981,642 
Chile1,923,821 1,814,658 1,687,090 
Jordan262,392 256,640 256,363 
Netherlands177,405 181,206 165,782 
China139,537 122,749 109,235 
Germany80,956 90,174 89,568 
France49,740 45,505 44,936 
Brazil29,474 24,393 37,165 
Other foreign countries62,667 66,273 68,499 
Total$6,502,834 $5,971,768 $5,443,776 
(a)    Long-lived assets are comprised of the Company’s Property, plant and equipment and joint ventures included in Investments.